Skip to content

Validation of an Artificial Intelligence System for Postoperative Management of Cataract Patients

Validation of an Artificial Intelligence System for Postoperative Management of Cataract Patients: A Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04138771
Enrollment
300
Registered
2019-10-24
Start date
2013-01-01
Completion date
2020-03-01
Last updated
2019-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Cataract, Postoperative Complications

Keywords

Conjunctival hyperemia, Pterygium, Intraocular lens dislocation, Posterior capsule opacification, Pupil malformation, Suppurative endophthalmitis

Brief summary

Cataract surgery is the current standard of management for cataract patients, which is typically succeeded by a postoperative follow-up schedule. Here, the investigators established and validated an artificial intelligence system to achieve automatic management of postoperative patients based on analyses of visual acuity, intraocular pressure and slit-lamp images. The management strategy can also change according to postoperative time.

Interventions

DEVICEAn artificial intelligence system for postoperative management of cataract patients

This system can detect multiple postoperative complications of cataract patients and then provide a management strategy.

Sponsors

Ministry of Health, China
CollaboratorOTHER_GOV
Xidian University
CollaboratorOTHER
Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who had surgery of cataract extraction combined with introcular lens implantation. * Patients should be aware of the contents and signed for the informed consent.

Design outcomes

Primary

MeasureTime frame
The proportion of accurate, mistaken and miss detection of this artificial intelligence diagnostic system.Up to 7 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026